Tech Spending Depriving Investors Hits Buybacks in 2026
Big tech’s heavy AI investments are pinching buyback payouts, reshaping capital allocation as investors weigh dividen...
What New Investors Should Know In 2023
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,127 articles
Trump White House Registers: Crypto Market Impacts
When a high profile government move hits a new domain in the headlines, markets pay attention. This piece breaks down...
Missed Nvidia? Missed Tesla? Marketing AI Emerges as Bet
A new AI-driven marketing platform is entering the market via a Reg A+ offering at $0.85 a share, aiming to mirror th...
Micron Just Something Even: Is It a Buy Opportunity in AI?
As AI drives demand for faster memory, Micron sits at the center of a cyclical industry that can fuel outsized moves....
NANC Investors Have 45-Day Blind Spot as Rates Rise
The NANC ETF, built to mirror congressional disclosure trades, is facing a tougher 2026 as interest rates move higher...
Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Billionaire Dalio Warned Coming Capital War: What It Means for Investors
A seasoned investor warns that the global financial system faces a new kind of threat: capital shifts driven by debt,...
This Bond Fund That Bets on Higher Rates Draws Buyers
A niche bond ETF focused on mid-tier CLO tranches is drawing buyers as rate expectations stay elevated. The fund aims...
NVIDIA Stock Losing Market Pressure: Stay or Sell in 2026
2026 is shaping up as the year Nvidia investors reconsider. While the stock once led the market, it now trails the S&...
This Stock Nearly 17-Bagger: A Fresh Look at AI Winners
AI market storms have created massive wealth for early believers. Explore a standout name that became this stock near...
CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Prediction: Will Worth Less XRP by 2027 — Investing
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status